Next-Generation Solutions in the mRNA Cancer Vaccines and Therapeutics Market
The burgeoning mRNA Cancer Vaccines and Therapeutics Market is witnessing exponential growth, with volume estimates projecting an increase from USD 6.25 million in 2024 to an impressive USD 39.01 million by 2035. This growth equates to a remarkable compound annual growth rate (CAGR) of 18.12%, indicative of a significant shift in how cancer is treated. The emergence of mRNA technology...
0 Commenti 0 condivisioni 200 Views 0 Anteprima